- (Pictured: Dr Beth Ollington) February 11 marks the International Day of Women and Girls in Science, and what better way to celebrate it than by getting to know our…
- It’s World Cancer Research Day – but at Anthony Nolan, our researchers pour their passion into discovering treatments and cures for blood cancers every day. Hundreds of clinical…
- Scott was the 9th patient in the UK to participate in a CAR T-cell therapy trial, following a relapse from Acute lymphoblastic leukaemia (ALL). Scott shares with us how this…
- With new breakthroughs in cell therapies, Dr Diana Hernandez, Director of Immune and Advanced Therapies at Anthony Nolan, explains the science behind these treatments, and how…
- Umbilical cord blood (UCB) has huge potential, not only as a successful alternative source of hematopoietic blood cells for transplant/clinical application, but in research and…
- The hope of PTCy Stem cell transplants can be a lifesaving treatment for someone with a blood cancer or blood disorder. But they often require a close genetic match to…
- At Anthony Nolan, we help facilitate over 1000 stem cell transplants a year to give patients a second chance at life, and our medical officers play a crucial role in this process…
- 30 years of lifesaving progress Since opening in 1996, ANRI has helped improve the outlook for patients and donors worldwide - shaping global clinical…
- A stem cell transplant is a curative treatment for blood cancers and blood disorders. The procedure involves replacing a patient’s stem cells with those of a tissue type-matched…
- Key highlights from the Anthony Nolan Research Institute Symposium In early March, we hosted a Symposium on the contributions by the Anthony Nolan Research Institute (…